SC

Shiv Charan Arora

Active Director Director DIN 08497112
DIN 08497112 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Shiv Charan Arora

Data last updated:

Shiv Charan Arora is a Director at Kayra Innopharm Private Limited (since 2019). The company operates in Pharma. Kayra Innopharm Private Limited reported revenue of ₹1.86 Cr (FY 2024).

DIN 08497112
Primary Designation Director
Industry Pharma
First Appointment 01 Jul 2019
Oldest Company Age 8 yrs
Largest company Kayra Innopharm Private Limited · ₹1.86 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kayra Innopharm Private Limited U52609DL2018PTC337261
Director01 Jul 20192018₹1.86 Cr (FY 2024)Active

Board colleagues of Shiv Charan Arora

Directorship timeline

Open interactive timeline →
Kayra Innopharm Private Limited
Premium access

Shareholding and investment profile for Shiv Charan Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiv Charan Arora

Shiv Charan Arora currently holds 1 directorship: Kayra Innopharm Private Limited (Director, since 01 Jul 2019, revenue ₹1.86 Cr (FY 2024)).

Shiv Charan Arora was first appointed on 01 Jul 2019 as Director at Kayra Innopharm Private Limited.

The current boards of Shiv Charan Arora's companies include Kushagra Arora (Kayra Innopharm Private Limited), Pragya Arora (Kayra Innopharm Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available